Echo Therapeutics, Inc. - FORM 10-K - EX-32.1 - CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT - April 15, 2015

Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - Echo Therapeutics, Inc.Financial_Report.xls
EX-32.2 - CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF - Echo Therapeutics, Inc.ex32-2.htm
EX-31.1 - CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO RULE 13A-14 (A) UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED, AS ADOPTED - Echo Therapeutics, Inc.ex31-1.htm
EX-23.2 - CONSENT OF WOLF & COMPANY, P.C., INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM. - Echo Therapeutics, Inc.ex23-2.htm
EX-23.1 - CONSENT OF BDO USA LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM. - Echo Therapeutics, Inc.ex23-1.htm
EX-21.1 - SUBSIDIARIES OF THE COMPANY. - Echo Therapeutics, Inc.ex21-1.htm
EX-10.43 - AMENDMENT TO LICENSE, DEVELOPMENT AND COMMERCIALIZATION AGREEMENT BETWEEN ECHO THERAPEUTICS, INC. AND MEDICAL TECHNOLOGIES - Echo Therapeutics, Inc.ex10-43.htm
EX-10.39 - LETTER OF AGREEMENT - Echo Therapeutics, Inc.ex10-39.htm
EX-10.40 - SECURITIES PURCHASE AGREEMENT DATED DECEMBER 18, 2014, BY AND BETWEEN THE COMPANY, PLATINUM PARTNERS VALUE ARBITRAGE FUND L.P., BEIJING - Echo Therapeutics, Inc.ex10-40.htm
10-K - FORM 10K - Echo Therapeutics, Inc.ecte10k_12312014.htm
EX-31.2 - CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO RULE 13A-14 (A) UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED, AS ADOPTED - Echo Therapeutics, Inc.ex31-2.htm
Exhibit 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report on Form 10-K of Echo Therapeutics, Inc. (the “Company”) for the fiscal year ended December 31, 2014 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Scott W. Hollander, President and Chief Executive Officer, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 /s/ Scott W. Hollander
Scott W. Hollander
President and Chief Executive Officer
(Principal Executive Officer)

April 15, 2015

Echo Therapeutics, Inc. Reports